A Promising Copper(II) Complex as Antifungal and Antibiofilm Drug against Yeast Infection

Similar documents
Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

CONTAGIOUS COMMENTS Department of Epidemiology

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

CONTAGIOUS COMMENTS Department of Epidemiology

Nystatin apollo

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

The Nuts and Bolts of Antibiograms in Long-Term Care Facilities

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Liofilchem. ID-AST systems

FerriNaphth: A Fluorescent Dosimeter for Redox Active Metals

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

Supplementary information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Can i take diflucan with antibiotics

Treatment of peritoneal dialysis associated fungal peritonitis

Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations

Workshop Summary and Action Items

Eavan G. Muldoon Consultant in Infectious Diseases, National Aspergillosis Centre, University Hospital of South Manchester.

Dr. C. MANIKANDAN, Director,

Antimicrobial Susceptibility Summary 2011

Antimicrobial Susceptibility Summary 2012

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

COMPARATIVE INFLUENCE RADIATION SCALE ON PHYSICAL AND CHEMICAL PROPERTIES OF VENOM OF SNAKE VIPERA LEBETINA OBTUSA

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Mark Your Calendars Now! Next Event Ships: September 14, 2015

Over 40 Posters/Abstracts in Support of TREK Presented at the 2004 ECCMID

Introduction to Antimicrobial Therapy

Recurrent Bacterial Vaginosis

PO. Vasan, Gandhinagar District, Gujarat, India, 3 Dean at Faculty of Pharmacy, Dharmsinh Desai University, Nadiad, Gujarat, India.

MICU Antibiotics and Associated Drug Interactions

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ANTIMICROBIAL THERAPY IN ICU

Yeast mastitis outbreak in a Brazilian dairy herd

SIMPLE U.V. SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF OFLOXACIN IN PHARMACEUTICAL FORMULATIONS

TEST REPORT ON THE ANTIBACTERIAL AND FUNGICIDAL EFFECTS OF THE PRODUCT. Herba Sept

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Can fluconazole treat c diff

A non-polyene antifungal antibiotic from Streptomyces albidoflavus PU 23

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system

Management of Antibiotic Resistant Pathogens. Zach Willis, MD, MPH Department of Pediatrics, UNC 11/8/2017

Antibiotic stewardship in long term care

Antimicrobial and toxicological profile of the new biocide Akacid plus Ò

Liofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms

NEW PEPTIDE ANTIBIOTICS LI-F03, F04, F05, F07, AND F08, PRODUCED BY BACILLUS POLYMYXA I. ISOLATION AND CHARACTERIZATION

Effect of amikacin, cephalothin, clindamycin and vancomycin on in vitro fibroblast growth

Development and Validation of UV Spectrophotometric Area Under Curve (AUC) method for estimation of Pyrantel Pamoate in Bulk and Tablet Dosage Form

OYRON WELL D-ONE Rev /10/2015

Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Susceptibility Summary 2017

Infection Linelist. Infections Occurred Between 10/1/ :00:00 AM To 11/1/ :00:00 AM 2RCW2. Gastroenteritis (Adult) Urinary Tract

Antimicrobial Activity of

SURVIVABILITY OF HIGH RISK, MULTIRESISTANT BACTERIA ON COTTON TREATED WITH COMMERCIALLY AVAILABLE ANTIMICROBIAL AGENTS

INVESTIGATOR. R. Vanhoof 1, Engelandstraat 642, B-1180 Brussel.

Corresponding author: Y. Wang

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Prudent Use of Antibiotics in Long Term Care Residents with Suspected UTI

Kamepalli Sujana et al. / Journal of Pharmacy Research 2014,8(12), Available online through

A snapshot of polymyxin use around the world South America

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

Stability Indicating Spectrophotometric Method of Amlodipine and Telmisartan in Bulk and Pharmaceutical Dosage Form

INTRASPECIFIC AGONISM BETWEEN GIANT OTTER GROUPS. Carolina Ribas 1. Guilherme Mourão 2. Campo Grande, MS , Brazil. Brazil.

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

RAPID IDENTIFICATION OF RESISTANCE MECHANISMS

Principles of Antimicrobial therapy

Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different media

Nosocomial respiratory tract infection in patients with liver cirrhosis

Please distribute a copy of this information to each provider in your organization.

4/4/2017. Update on Diagnostic Assays for Rapid Detection of Bacteremia. Disclosures. Learning Objectives

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

biomérieux S.A Marcy l Etoile France Tel. : 33 (0) Fax : 33 (0)

Diagnosis: Presenting signs and Symptoms include:

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Stanford Antimicrobial Safety and Sustainability Program Antimicrobial Restriction Policy

Management of Antibiotic Resistant Pathogens. Zach Willis, MD, MPH Department of Pediatrics, UNC 11/6/2018

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets

Revista Brasileira de Anestesiologia

Microbiology Department, Charing Cross Hospital Medical School, London PLATES XXVII AND XXVIII

Antibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center

Supplemental Information. Discovery of Reactive Microbiota-Derived. Metabolites that Inhibit Host Proteases

Chapter 8 Antimicrobial Activity of Callus Extracts of Justicia adhatoda L. in Comparison with Vasicine

Received: 1 August 2011; in revised form: 11 October 2011 / Accepted: 8 November 2011 / Published: 25 November 2011

Concentration of Enrofloxacin Residue from Tilapia (Oreochromis niloticus) Muscular That Infected by Aeromonas salmonicida

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Introduction to Antimicrobial Therapy

6. STORAGE INSTRUCTIONS

TITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Vet N E W S A N D I N S I G H T F O R T H E V E T E R I N A RY M I C R O B I O L O G Y L A B O R ATO RY. TREK Introduces Two New Veterinary Plates!

Resistance to cloxacillin among hospital staphylococci.

Management of CRBSI Leilani Paitoonpong MD MSc Chusana Suankratay MD PhD Division of Infectious Diseases Chulalongkorn University

FROM THE NEWSLETTER EDITOR S DESK

David C Okechukwu 1, Mumuni A. Momoh 1, Charles O Esimone 2

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Determination of Amlodipine in Rat Plasma by UV Spectroscopy

BIOTRANSFORMATION, A NEW APPROACH TO AMINOGLYCOSIDE BIOSYNTHESIS : II GENTAMICIN. R.T. TESTA and B.C. TILLEY

Transcription:

A Promising Copper(II) Complex as Antifungal and Antibiofilm Drug against Yeast Infection Fabiana Gomes da Silva Dantas 1, Adriana Araújo de Almeida-Apolonio 2, Renata Pires de Araújo 3, Lis Regiane Vizolli Favarin 4, Pamella Fukuda de Castilho 1, Fernanda de Oliveira Galvão 1, Terezinha Inez Estivalet Svidzinski 5, Gleison Antônio Casagrande 4, * and Kelly Mari Pires de Oliveira 1,6, * 1 Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS 7984-97, Brazil; fabianasilva@ufgd.edu.br (F.G.d.S.D.); pamellafcastilho@gmail.com (P.F.d.C.); feergalvao@hotmail.com (F.d.O.G.) 2 Faculty of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, MS 797-9, Brazil; aaraujo.a@hotmail.com (A.A.d.A.A) 3 Faculty of Exact Sciences and Technology, Federal University of Grande Dourados, Dourados, MS 7984-97, Brazil; renataaraujo@ufgd.edu.br (R.P.d.A) 4 Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, MS 7974-46, Brazil; lisregiane@hotmail.com (L.R.V.F) 5 Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, PR 872-9, Brazil; terezinha.svidzinski@gmail.com (T.I.E.S) 6 Faculty of Biological and Environmental Science, Federal University of Grande Dourados, Dourados, MS 7984-97, Brazil * Correspondence: gleisoncasag@gmail.com (G.A.C.); kellyoliveira@ufgd.edu.br (K.M.P.d.O.); Tel.: +55-67-3345-3595 (G.A.C.); +55-67-341-222 (K.M.P.d.O.) Received: 9 June 218; Accepted: 26 June 218; Published: date Molecules 218, 23, 1856; doi:1.339/molecules2381856 www.mdpi.com/journal/molecules

Table S1. Anti-Candida activity of the complex 2 [CuCl2Bipy(L2)], free ligands (2-thiouracil and 6-methyl-2-thiouracil) and cooper(ii) chloride in planktonic cells by microdilution in broth technique (µg/ml). Isolate Source Complex 2 [CuCl2Bipy(L2)] 2-thiouracil 6-methyl-2- thiouracil CuCl2 FLC c AmB d MIC a MFC b MIC a MFC b MIC a MFC b MIC a MFC b C. albicans CA1 Sputum >1 >1 >1 >1 >1 >1 1 1.5.5 C. albicans CA2 Sputum >1 >1 >1 >1 >1 >1 1 1.25.25 C. albicans CA3 Vaginal >1 >1 >1 >1 >1 >1 1 1.5.5 C. albicans CA4 Vaginal >1 >1 >1 >1 >1 >1 1 1.5.5 C. albicans CA5 Vaginal >1 >1 >1 >1 >1 >1 1 1.5.5 C. albicans CA6 Vaginal >1 >1 >1 >1 >1 >1 1 1.5.5 C. albicans CA7 Nasal swab >1 >1 >1 >1 >1 >1 1 1.25.5 C. albicans CA8 Urine >1 >1 >1 >1 >1 >1 1 1.25.5 C. albicans CA9 Vaginal >1 >1 >1 >1 >1 >1 1 1.25.5 C. albicans CA1 Vaginal >1 >1 >1 >1 >1 >1 1 1.5.5 C. glabrata CG1 Urine >1 >1 >1 >1 >1 >1 1 1 16 e.3 Molecules 218, 23, 1856; doi:1.339/molecules2381856 www.mdpi.com/journal/molecules

Molecules 218, 23, 1856 2 of 11 C. glabrata CG2 Urine >1 >1 >1 >1 >1 >1 1 1 1.3 C. glabrata CG3 Urine >1 >1 >1 >1 >1 >1 1 1 16 e.5 C. glabrata CG4 Urine >1 >1 >1 >1 >1 >1 1 1 1.3 C. glabrata CG5 Blood >1 >1 >1 >1 >1 >1 1 1 32 e.3 C. glabrata CG6 Urine >1 >1 >1 >1 >1 >1 1 1 16 e.5 C. krusei CK1 Rectal swab >1 >1 >1 >1 >1 >1 1 1.5.3 C. parapsilosis CP1 Blood >1 >1 >1 >1 >1 >1 1 1.25.25 C. parapsilosis CP2 Catheter tip >1 >1 >1 >1 >1 >1 1 1.25.3 C. parapsilosis CP3 Urine >1 >1 >1 >1 >1 >1 1 1.25.3 C. tropicalis CT1 Sputum >1 >1 >1 >1 >1 >1 1 1 2.5 a MIC: Minimum Inhibitory Concentration (µg/ml); b MFC: Minimum Fungicidal Concentration (µg/ml); c FLC: Fluconazole (µg/ml); AmB: d Amphotericin B (µg/ml); e Susceptible Dose-Dependent (SDD) (µg/ml).

Molecules 218, 23, 1856 3 of 11 Complex 1 Intens..5 157.759 26.27 375.667 lis-1_pos_1-46_1_9435.d: +MS,.4min #56. 2 1 Intens. 1 x1 4 4 2 4 2 6 Intens. 4 x1 4 2 2 2 1 1 237.76 237.75 Figure S1. ESI-HRMS spectrum of the complex 1. lis-1_pos_1-46_1_9435.d: +MS2(375.667), 35.eV,.4min #57 lis-1_pos_1-46_1_9435.d: +MS2(26.27), 35.eV,.4min #58 lis-1_pos_1-46_1_9435.d: +MS,.4min #56 375.667 2 3 4 5 377.659 376.694 6 7 378.682 8 9 1 11 m/z 376.2529 lis-1_pos_1-46_1_9435.d: +MS2(375.667), 35.eV,.4min #57 lis-1_pos_1-46_1_9435.d: +MS2(26.27), 35.eV,.4min #58 26.27 lis-1_pos_1-46_1_9435.d: +MS,.4min #56 372 3+ 374 262.255 376 261.293 263.267 264.64 378 38 382 m/z lis-1_pos_1-46_1_9435.d: +MS2(375.667), 35.eV,.4min #57 26.25 265.427 262.299 Zoom in 26.27 emphasis on the isotopic 263.281distribution of copper. 266.372 267.434 26.264 lis-1_pos_1-46_1_9435.d: +MS2(26.27), 35.eV,.4min #58 261.289 Full spectrum Zoom in 375.667 emphasis on the isotopic distribution of copper. 262.244 265.42 256 258 26 262 264 266 268 27 272 274 m/z 267.49

Molecules 218, 23, 1856 4 of 11 Complex 2 Intens..5 375.648 157.76 26.272 237.71 lis-2_pos_1-47_1_9437.d: +MS,.6min #62. 1..5. 1 237.66 237.62 Full spectrum lis-2_pos_1-47_1_9437.d: +MS2(26.272), 35.eV,.6min #63 lis-2_pos_1-47_1_9437.d: +MS2(237.71), 35.eV,.6min #64 5 Intens. x1 4 2 1 1..75.5 Intens..25.8. 8.6.4 6.2 4. 2 1 75 5 25 12.5 1. 7.5 5. 2.5. 154.616 lis-2_pos_1-47_1_9437.d: +MS,.6min #62 237.71 2 3 4 5 6 7 8 9 1 11 m/z Figure S2. ESI-HRMS spectrum of the complex 2. 237.66 Zoom in 237.71 emphasis on the isotopic distribution of copper. 237.62 238.11 238.82 239.65 239.61 24.133 lis-2_pos_1-47_1_9437.d: +MS2(26.272), 35.eV,.6min #63 lis-2_pos_1-47_1_9437.d: +MS,.6min #62 24.85 lis-2_pos_1-47_1_9437.d: +MS2(237.71), 35.eV,.6min #64 239.76 lis-2_pos_1-47_1_9437.d: +MS2(26.272), 35.eV,.6min #63 226 228 23 232 234 236 238 24 242 m/z 375.648 377.638 Zoom in 357.648 emphasis on the isotopic distribution of copper. lis-2_pos_1-47_1_9437.d: +MS2(237.71), 35.eV,.6min #64 34 35 36 37 38 39 m/z

Molecules 218, 23, 1856 5 of 11 Figure S3. Cuvettes containing the solutions of the complex 1 (light green) and ligand (colorless). Picture taken during the experiment. Complex 2 and respective ligand have been presented similar behavior.

Molecules 218, 23, 1856 6 of 11 Figure S4. UV-Vis absorption spectra of the complex 1 and respective ligand measured at 298 K. This experiment was performed 36 h after preparing the solutions.

Absorption (a.u) Absorption (a.u) Molecules 218, 23, 1856 7 of 11 55 6 65 7 75 8 Wavelength (nm) Complex (2) Ligand (2) 25 3 35 4 45 5 55 6 65 7 75 Wavelength (nm) Figure S5. UV-Vis absorption spectra of the complex 2 and respective ligand measured at 298 K. This experiment was performed 36 h after preparing the solutions.

Molecules 218, 23, 1856 8 of 11 Figure S6. Green solid of the Complex 1 obtained after filtration. Figure S7. Green solid of the Complex 2 obtained after filtration.

Molecules 218, 23, 1856 9 of 11 Possible Fragments of the complex 1

Molecules 218, 23, 1856 1 of 11 Possible fragments of the complex 2